Literature DB >> 2209546

Characterization of recombinant human factor IX expressed in transgenic mice and in derived trans-immortalized hepatic cell lines.

S Jallat1, F Perraud, W Dalemans, A Balland, A Dieterle, T Faure, P Meulien, A Pavirani.   

Abstract

Transgenic mice were generated in which 5 kb of the 5' flanking promoter region of the human Factor IX (FIX) gene fused to various FIX constructs (gene, minigene and cDNA) were stably integrated in the germ line. Several transgenic mouse lines expressed high circulating levels of active and correctly processed recombinant human FIX. The presence of at least one FIX intron had a positive effect on the expression. The FIX transgenes were expressed in a tissue-specific manner in the liver of transgenic mice. By crossing transgenic mice synthesizing FIX with others prone to develop hepatoma, progeny which co-express the transgenes in hepatocytes were obtained. Hepatoma-derived cell lines were shown to have a differentiated phenotype and secrete active human FIX for many generations.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2209546      PMCID: PMC552066          DOI: 10.1002/j.1460-2075.1990.tb07529.x

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  38 in total

1.  Detection of specific sequences among DNA fragments separated by gel electrophoresis.

Authors:  E M Southern
Journal:  J Mol Biol       Date:  1975-11-05       Impact factor: 5.469

2.  Nucleotide sequence of the gene for human factor IX (antihemophilic factor B).

Authors:  S Yoshitake; B G Schach; D C Foster; E W Davie; K Kurachi
Journal:  Biochemistry       Date:  1985-07-02       Impact factor: 3.162

3.  Comparison between hepatic and nonhepatic vitamin K-dependent carboxylase.

Authors:  C Vermeer
Journal:  Haemostasis       Date:  1986

4.  Expression, purification, and characterization of recombinant gamma-carboxylated factor IX synthesized in Chinese hamster ovary cells.

Authors:  R J Kaufman; L C Wasley; B C Furie; B Furie; C B Shoemaker
Journal:  J Biol Chem       Date:  1986-07-25       Impact factor: 5.157

5.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

Review 6.  Blood coagulation.

Authors:  C M Jackson; Y Nemerson
Journal:  Annu Rev Biochem       Date:  1980       Impact factor: 23.643

7.  Expression of active human factor IX in transfected cells.

Authors:  S Busby; A Kumar; M Joseph; L Halfpap; M Insley; K Berkner; K Kurachi; R Woodbury
Journal:  Nature       Date:  1985 Jul 18-24       Impact factor: 49.962

8.  Characterization of protein S, a gamma-carboxyglutamic acid containing protein from bovine and human plasma.

Authors:  R G DiScipio; E W Davie
Journal:  Biochemistry       Date:  1979-03-06       Impact factor: 3.162

9.  Isolation and characterization of human factor VII. Activation of factor VII by factor Xa.

Authors:  S P Bajaj; S I Rapaport; S F Brown
Journal:  J Biol Chem       Date:  1981-01-10       Impact factor: 5.157

10.  Purification of mouse immunoglobulin heavy-chain messenger RNAs from total myeloma tumor RNA.

Authors:  C Auffray; F Rougeon
Journal:  Eur J Biochem       Date:  1980-06
View more
  10 in total

Review 1.  The mammary gland as a bioreactor: expression, processing, and production of recombinant proteins.

Authors:  A J Clark
Journal:  J Mammary Gland Biol Neoplasia       Date:  1998-07       Impact factor: 2.673

2.  Vascular damage without hypertension in transgenic rats expressing prorenin exclusively in the liver.

Authors:  M Véniant; J Ménard; P Bruneval; S Morley; M F Gonzales; J Mullins
Journal:  J Clin Invest       Date:  1996-11-01       Impact factor: 14.808

Review 3.  From in vitro to in vivo. Progress in the use of cultured cells for human therapy.

Authors:  W Dalemans
Journal:  Cytotechnology       Date:  1994       Impact factor: 2.058

4.  Accumulation of functional recombinant human coagulation factor IX in transgenic soybean seeds.

Authors:  Nicolau B Cunha; André M Murad; Gustavo L Ramos; Andréia Q Maranhão; Marcelo M Brígido; Ana Cláudia G Araújo; Cristiano Lacorte; Francisco J L Aragão; Dimas T Covas; Aparecida M Fontes; Gustavo H M F Souza; Giovanni R Vianna; Elíbio L Rech
Journal:  Transgenic Res       Date:  2010-11-11       Impact factor: 2.788

5.  Fixing human factor IX (fIX): correction of a cryptic RNA splice enables the production of biologically active fIX in the mammary gland of transgenic mice.

Authors:  F Yull; G Harold; R Wallace; A Cowper; J Percy; I Cottingham; A J Clark
Journal:  Proc Natl Acad Sci U S A       Date:  1995-11-21       Impact factor: 11.205

6.  Proteolytic maturation of protein C upon engineering the mouse mammary gland to express furin.

Authors:  R Drews; R K Paleyanda; T K Lee; R R Chang; A Rehemtulla; R J Kaufman; W N Drohan; H Luboń
Journal:  Proc Natl Acad Sci U S A       Date:  1995-11-07       Impact factor: 11.205

7.  Development of a transgenic mouse model with immune tolerance for human coagulation factor VIIa.

Authors:  Christine Lenk; Sabine Unterthurner; Maria Schuster; Markus Weiller; Gerhard Antoine; Mantas Malisauskas; Friedrich Scheiflinger; Hans-Peter Schwarz; Maurus de la Rosa; Birgit M Reipert
Journal:  Pharm Res       Date:  2013-06-18       Impact factor: 4.200

8.  Novel cell lines derived from transgenic mice expressing recombinant human proteins. Transgenic hepatoma-derived cell lines.

Authors:  F Perraud; W Dalemans; D Ali-Hadji; A Pavirani
Journal:  Cytotechnology       Date:  1992       Impact factor: 2.058

9.  Low-Dose Gene Therapy for Murine PKU Using Episomal Naked DNA Vectors Expressing PAH from Its Endogenous Liver Promoter.

Authors:  Hiu Man Grisch-Chan; Andrea Schlegel; Tanja Scherer; Gabriella Allegri; Raphael Heidelberger; Panagiota Tsikrika; Marco Schmeer; Martin Schleef; Cary O Harding; Johannes Häberle; Beat Thöny
Journal:  Mol Ther Nucleic Acids       Date:  2017-04-20

10.  Functions of the Heterologous Intron-Derived Fragments Intra and Extra Factor IX-cDNA Coding Region on the Human Factor IX Expression in HepG2 and Hek-293T Cells.

Authors:  Mohammad Reza Sam; Alireza Zomorodipour; Aliakbar Haddad-Mashadrizeh; Mahdi Ghorbani; Gholam Ali Kardar; Sohrab Sam
Journal:  Iran J Biotechnol       Date:  2018-05-15       Impact factor: 1.671

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.